ZORSANVI

Serial Number 87661529
606

Registration Progress

Application Filed
Oct 26, 2017
Under Examination
Apr 17, 2018
Approved for Publication
Feb 20, 2018
Published for Opposition
Feb 20, 2018
Registered

Trademark Image

ZORSANVI

Basic Information

Serial Number
87661529
Filing Date
October 26, 2017
Published for Opposition
February 20, 2018
Abandonment Date
May 24, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 24, 2021
Classes
005

Rights Holder

Ionis Pharmaceuticals, Inc.

03
Address
2855 Gazelle Court
Carlsbad, CA 92010

Ownership History

Ionis Pharmaceuticals, Inc.

Original Applicant
03
Carlsbad, CA

Ionis Pharmaceuticals, Inc.

Owner at Publication
03
Carlsbad, CA

Legal Representation

Attorney
Anne H. Peck

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
May 24, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 24, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 14, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 7, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 10, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 15, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 15, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 11, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 26, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 24, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 24, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 24, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 10, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 8, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 8, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 8, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 20, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 31, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 12, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 27, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 21, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2017 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 21, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 18, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 5, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin

Classification

International Classes
005